Progenra, Inc. is dedicated to finding new medicines for a variety of diseases by targeting the ubiquitin pathway.

Progenra’s mission is to leverage its expertise in the ubiquitin-proteasomal pathway of cellular protein regulation, acquired over several years, to:
1) Discover and develop medicines to fill unmet medical needs in a spectrum of therapeutic areas.
2) Create research tools that will enable translational studies of the pathway.

Sector: Healthcare
Status: Alumni

Contact Information

Tauseef Butt

CEO and Co-Founder

Michael Mattern